| GIP | glucose-dependent insulinotropic polypeptide (previously known as gastric inhibitory peptide) |
| GLP1 | glucagon-like peptide 1 |
| T2D | type 2 diabetes |
| GLP1R | glucagon-like peptide 1 receptor |
| GLP1RA | glucagon-like peptide 1 receptor agonist |
| DPP4 | dipeptidyl peptidase 4 |
| DPP4i | dipeptidyl peptidase 4 inhibitor |
| DKD | diabetic kidney disease |
| T1D | type 1 diabetes |
| ESRD | end stage renal disease |
| GRF | glomerular filtration rate |
| KRT | kidney replacement therapy |
| PCSK1 | proprotein convertase subtilisin-kexin type 1 |
| PCSK3 | proprotein convertase subtilisin-kexin type 3 |
| cAMP | cyclic adenosine monophosphate |
| NEP | neutral endopeptidase (neprilysin) |
| Fc | fragment crystallizable |
| XR | extended release |
| SNAC | sodium N-(8-[2-hydroxybenzoyl]amino) caprylate |
| HbA1c | haemoglobin A1c |
| CVOT | cardiovascular outcome trial |
| LEADER trial | the Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results trial |
| eGFR | estimated glomerular filtration rate |
| SUSTAIN-6 trial | the Trial to Evaluate Cardiovascular and Other Long-Term Outcomes with Semaglutide in Subjects with Type 2 Diabetes trial |
| EXSCEL trial | the Exenatide Study of Cardiovascular Event Lowering trial |
| CARMELINA trial | the Cardiovascular and Renal Microvascular Outcome Study with Linagliptin trial |
| UACR | urine albumin-to-creatinine ratio |
| SAVOR-TIMI 53 trial | the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus—Thrombosis in Myocardial Infraction trial |
| AGE | advanced glycation end-product |
| AOPP | advanced oxidation protein product |
| NADPH | reduced form of nicotinamide adenine dinucleotide phosphate |
| NF-ĸB | nuclear factor ĸB |
| TGF-β | transformin growth factor-β |
| ERα | oestrogen receptor α |
| ERβ | oestrogen receptor β |
| GLUT4 | glucose transporter type 4 |
| NHE3 | sodium-hydrogen exchanger 3 |
| SDF1α | stromal cell-derived factor 1α |
| ICAM1 | intercellular adhesion molecule 1 |
| TLR2 | toll-like receptor 2 |
| TLR4 | toll-like receptor 4 |
| TNF | tumour necrosis factor |
| IL-1B | interleukin 1B |
| MAPK8 | mitogen-activated protein kinase 8 |
| SOCS3 | suppressor of cytokine signalling 3 |
| CCl2 | C-C motif chemokine ligand 2 |
| NGAL | neutrophil gelatinase-associated lipocalin |
| CRP | C reactive protein |
| IL-6 | interleukin 6 |
| IL-18 | interleukin 18 |
| LDL | low density lipoprotein |
| HDL | high density lipoprotein |